Summary:
- This article, published in *Nature Reviews Endocrinology*, provides a comprehensive analysis of the clinical implications of GLP-1 receptor agonists in the management of obesity and type 2 diabetes.
- It synthesizes current research on the pleiotropic effects of incretin-based therapies, highlighting their impact on metabolic health, cardiovascular outcomes, and the evolving landscape of precision endocrinology.